Altalube

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Altalube
Generic name: MINERAL OIL AND PETROLATUM
Manufacturer: Altaire Pharmaceuticals Inc.
Product type: HUMAN OTC DRUG
SPL set ID: eb65004c-c3a7-4079-bd75-f2857d30c68a
SPL ID: 0c0e9c0d-6205-e63b-e063-6294a90ac0d9
Version: 4
Effective date: 2023-12-09
Source export date: 2026-09-28
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:24:16

Harmonized routes table
Harmonized routes
OPHTHALMIC

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M018	openfda.application_number
brand name		Altalube	openfda.brand_name
generic name		MINERAL OIL AND PETROLATUM	openfda.generic_name
manufacturer name		Altaire Pharmaceuticals Inc.	openfda.manufacturer_name
ndc	package	59390-198-50	openfda.package_ndc
ndc	product	59390-198	openfda.product_ndc
ndc11	package	59390019850	derived:openfda.package_ndc
rxcui		579996	openfda.rxcui
rxcui		1088146	openfda.rxcui
spl id		0c0e9c0d-6205-e63b-e063-6294a90ac0d9	id
spl set id		eb65004c-c3a7-4079-bd75-f2857d30c68a	set_id
unii		4T6H12BN9U	openfda.unii
unii		T5L8T28FGP	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings • Save box for complete information. • For use in the eyes only. When using this product • avoid contamination, do not touch tip of container to any surface. • replace cap after each use. Stop use and ask a doctor if • you experience eye pain, changes in vision, continued redness or irritation of the eye. • condition worsens or persists for more than 72 hours. Keep this and all drugs out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.